There are two kinds of protein aggregates associated with Alzheimer’s disease: amyloid-beta and tau aggregates. Protein ligands are molecules with the ability to bind to these pathologicalprotein accumulations, and if the ligands are fluorescent, they can be used to detect the aggregates they’re bound to. The ligands can be selective and only bind to one kind of protein aggregate, or they can be general and bind to both kinds. PI-2620 is a ligand selective for tau aggregates, and in this thesis, three analogues of PI-2620 were synthesized and determined to be functional fluorescent protein ligands. Two of them, designated A1 and B1, were selective for amyloid-beta aggregates, while the third ligand, A2, obtained by ester-hydrolysis of A1, would bind to both tau and amyloid-beta aggregates. This finding suggests that introducing a charge to a ligand lowers its selectivity, since the staining experiments were carried out in a buffered solution at pH 7.4, where ligand A2 might be partially charged.